convertible

Vaxcyte plans to use the proceeds for clinical development of VAX-31, funding trials, manufacturing scale-up, inventory, global capacity, commercial launch preparation, advancing medical affairs, commercial infrastructure, early pipeline R&D, and…

Semtech Corporation (NASDAQ:SMTC) has priced a $350M private placement of 0% convertible senior notes due 2030 to qualified institutional buyers. The company granted initial purchasers an option to buy up…